ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FA03 | BioTech | Obinutuzumab - 1000mg/40ml | 8201/388 | 55715/1 | GAZYVA | 1000mg/40ml | 1 | Injectable concentrate for solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FA03 | BioTech | Obinutuzumab - 1000mg/40ml | 8201 | 55715/1 | GAZYVA | 1000mg/40ml | 1 | Injectable concentrate for solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | 314,437,416 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 12/12/20 | 0 |